Case Study: Genesis Therapeutics achieves 3x faster AI model training with Lambda

Genesis Therapeutics speeds model training 3x with Lambda

Genesis Therapeutics, a company specializing in AI-driven drug discovery, faced significant computational bottlenecks as its research expanded to more complex protein targets. Their model training times stretched to months, hindered by scalability issues and networking bottlenecks. To overcome this, they partnered with vendor Lambda to leverage its high-performance AI cloud and 1-Click Cluster service.

By implementing Lambda's NVIDIA H100 GPU clusters with high-speed InfiniBand networking, Genesis Therapeutics achieved a 3x reduction in training times, cutting model training from months to just a week. This solution from Lambda provided the flexible, scalable compute power needed to process larger datasets and improve model accuracy, accelerating research on previously undruggable proteins and allowing the team to focus on discovery rather than infrastructure.

Genesis Therapeutics